Researchers continue to excited about this new drug, a innovative dual treatment showing remarkable data in clinical trials for body loss . It works by targeting two pathways : GLP-1 and GIP, that , when activated , help influence cravings and enhance calorie burn. Preliminary observations indicate substantial weight loss and possible benefits for